Abstract: Provided is a method of calculating volcanic ash dispersion prediction information in real time. The method according to an embodiment of the present disclosure includes collecting volcanic ash advisory texts and weather forecast data in real time, preprocessing the collected volcanic ash advisory texts and weather forecast data, and calculating a volcanic ash eruption rate using some of the preprocessed volcanic ash advisory texts and weather forecast data.

Abstract: The present invention relates to a method of manufacturing an animal cartilage-derived injectable composition, an injectable composition manufactured by the method, and a use thereof. The injectable composition of the present invention includes a collagen-containing biomaterial in a formulation injectable into joint cavity and may induce cartilage tissue regeneration by repairing tissue via direct injection to a target region without surgical incision. In addition, the injectable composition may be used as a therapeutic agent for arthritis by alleviating osteoarthritis not only because the animal cartilage-derived extracellular matrix contained in the injectable composition protects articular cartilage tissue but also because an environment capable of regenerating damaged articular tissue is created by inducing differentiation of intra-articular stem cells into chondrocytes.

Abstract: Disclosed in the present invention is a vehicle heat pump system capable of improving dehumidification performance by increasing the flow of a refrigerant toward an evaporator during heating and dehumidifying modes. The vehicle heat pump system comprises: a bypass line which branches off between a first expansion valve and an outdoor heat exchanger and bypasses through the outdoor heat exchanger and the evaporator; a first refrigerant flow control valve for adjusting the opening degree between the bypass line and a refrigerant line toward the outdoor heat exchanger; a dehumidification line branching off between the first expansion valve and the first refrigerant flow control valve to supply the refrigerant to the evaporator; and a control unit for controlling the amount of refrigerant supplied to the dehumidification line according to outdoor air temperature or compressor RPM.

Abstract: Heat pump system for a vehicle and method for controlling same, which can, during mode changing between air heating and conditioning, prevent noise and vibration due to a pressure difference between refrigerants and reduce delay time. Heat pump system comprises a compressor compressing and discharging refrigerant, an indoor heat exchanger in air conditioning case, causing the refrigerant discharge from the compressor to heat the air, a first expansion valve for selectively expanding the refrigerant passed through the indoor heat exchanger, an evaporator in air conditioning case, enabling refrigerant to exchange heat with air evaporating refrigerant, and a controller for controlling the opening degree of the first expansion valve during mode changing between air heating and conditioning, wherein the controller turns off the compressor and gradually opens the first expansion valve to increase the opening degree when the mode is changed from the heat pump mode to the air conditioning mode.

Abstract: An assembly for a seat includes a pivot hub defining multiple rotation axes, and a displacing module attached to the pivot hub. Extendable legs are rotatably coupled to the pivot hub and comprise locking devices movable between an unlocked position, in which the legs, when extended, are enabled to retract, and a locked position, in which the legs, when extended, are prevented from retracting. The legs are rotatable between an intermediate position and a deployed position. When the legs are extended, and when in the intermediate position, the displacing module engages the locking devices to move the locking devices from the locked position to the unlocked position. When the legs are extended, rotating the legs from the intermediate position to the deployed position brings the displacing module out of contact with the locking devices.

Abstract: A non-aqueous electrolyte for a lithium secondary battery and a lithium secondary battery including the same are disclosed herein. In some embodiments, a non-aqueous electrolyte for a lithium secondary battery includes an organic solvent, a lithium salt, and a compound represented by Formula 1. In some embodiments, the compound represented by Formula 1 is present in an amount of 0.5 part by weight to 5 parts by weight based on 100 parts by weight of the non-aqueous electrolyte.

Abstract: A method of activating a secondary battery includes an operation of deriving a reduction reaction voltage according to an electrolyte additive, a pre-charging operation of pre-charging the secondary battery into which an electrolyte containing the electrolyte additive is injected, and a pre-aging operation of wetting an electrode assembly accommodated in the secondary battery with the injected electrolyte and aging the electrode assembly. A charging termination voltage in the pre-charging operation is less than the reduction reaction voltage.

Abstract: Provided is a method performed by a least one computing device for a message service. The method comprises receiving a transmission request for a compound message which is a bundled message comprising a parent message and a plurality of child messages, obtaining permission information for a sender of the compound message, determining whether to allow each of the child messages to be sent based on the permission information and controlling transmission of the compound message based on the determination result.

Abstract: The present invention provides a pharmaceutical composition for preventing or treating inflammatory diseases, containing, as an active ingredient, stem cells overexpressing SOD3. The present inventor has ascertained that mesenchymal stem cells (MSCs) overexpressing SOD3 have a stronger antioxidant activity and immune regulatory function than normal MSCs, and thus the MSCs overexpressing SOD3 can be an effective treatment agent for inflammatory diseases, autoimmune diseases, organ transplant rejection and the like.

Abstract: A non-aqueous electrolyte solution for a lithium secondary battery includes a compound represented by Formula 1 as follows, a lithium salt, and an organic solvent; and a lithium secondary battery including the same: wherein R1 to R3, L1 and A? are described herein.

Abstract: The present invention relates to a pharmaceutical composition that is for treating pancreatic cancer and contains a nucleic acid complex as an active ingredient, and more specifically, to a pharmaceutical composition that is for preventing or treating pancreatic cancer and contains a nucleic acid complex in which a bioactive peptide nucleic acid, having a sequence binding to the KRAS gene, and a carrier peptide nucleic acid are complementarily bound. The nucleic acid complex according to the present invention has excellent cell permeability and intracellular activity, and can effectively inhibit the expression of the KRAS gene and subtype genes thereof, and is thus useful for the prevention or treatment of pancreatic cancer.

Abstract: An assembly for a seat includes a pivot hub defining multiple rotation axes, and a displacing module attached to the pivot hub. Extendable legs are rotatably coupled to the pivot hub and comprise locking devices movable between an unlocked position, in which the legs, when extended, are enabled to retract, and a locked position, in which the legs, when extended, are prevented from retracting. The legs are rotatable between an intermediate position and a deployed position. When the legs are extended, and when in the intermediate position, the displacing module engages the locking devices to move the locking devices from the locked position to the unlocked position. When the legs are extended, rotating the legs from the intermediate position to the deployed position brings the displacing module out of contact with the locking devices.

Abstract: The present invention relates to a use of a cell adhesion molecule-related/down-regulated by oncogene (Cdo) protein or a gene encoding the same for preventing or treating neuromuscular diseases caused by damage to motor neurons, particularly muscle stem cells and neuromuscular junctions, due to aging, oxidative stress, and the like; and a method for screening for candidates for activating the expression of Cdo. When Cdo is deleted in motor neurons or neuromuscular junctions, aggravation of damage to degenerative motor neurons due to aging, and DNA damage caused by oxidative stress and inflammation are caused, which may cause neuromuscular diseases. Thus, the diseases can be treated through overexpression and activity of the Cdo protein and the gene encoding the same.

Abstract: The present invention relates to a composition for preparing a decellularized scaffold, including nano graphene oxide. The present inventors crosslinked nano graphene oxide to a decellularized liver scaffold to strengthen the properties of the scaffold and suppress protease activity of the scaffold, and thus have established an optimum crosslinking condition exhibiting the effects of anti-inflammation and polarization to M2 macrophages. That is, since it is confirmed that nano graphene oxide strengthens the durability of the scaffold so that biodegradation is suppressed and, simultaneously, inflammatory responses that may occur after transplantation are minimized, it is expected that nano graphene oxide can be effectively used in the production and transplantation of clinically applicable artificial organs.

Abstract: A method of activating a secondary battery includes an operation of deriving a reduction reaction voltage according to an electrolyte additive, a pre-charging operation of pre-charging the secondary battery into which an electrolyte containing the electrolyte additive is injected, and a pre-aging operation of wetting an electrode assembly accommodated in the secondary battery with the injected electrolyte and aging the electrode assembly. A charging termination voltage in the pre-charging operation is less than the reduction reaction voltage.

Abstract: Provided is a method for constructing an atopic dermatitis skin organoid from human pluripotent stem cells. It was observed that ALI-skin organoids of the presently claimed subject matter formed skin cells, appendages, neural cells, adipocytes, and the like in similar structures to those in the real skin and exhibited greatly improved follicle growth, compared to skin organoids constructed by existing culture methods. In addition, as a result of treatment with Staphylococcus aureus to construct an atopic dermatitis model, a good simulation was made of the characteristics of atopic dermatitis, such as damaged skin barriers, increased epithelium-derived cytokines and downregulated epidermal stem cell expression, causing Staphylococcus aureus colonies, and the like. Thus, the skin organoid of the presently claimed subject matter is expected to find advantageous applications as a real skin model and an atopic dermatitis model.

Abstract: The present invention relates to a use for, by using the protein arginine methyltransferase 1 (PRMT1) protein or a gene encoding the same, preventing or treating a neuromuscular disease induced by motor neurons, particularly, damage to motor neurons caused by oxidative stress in the neuromuscular junction; and a method for screening a candidate material for activating the expression of PRMT1. PRMT1 deficiency in the motor nerve or neuromuscular junction induces aggravated degenerative motor nerve damage caused by aging, and DNA damage caused by oxidative stress and inflammation, thereby enabling the induction of neuromuscular disease, and thus the disease may be treated through the overexpression and activity of the PRMT1 protein and a gene encoding the same.

Abstract: The present disclosure related to a non-aqueous electrolyte solution for a lithium secondary battery, the non-aqueous electrolyte solution comprising: a lithium salt; an organic solvent; and a first additive, wherein the first additive is one or two of compounds represented by following chemical formula 1a and chemical formula 1b:

Abstract: The present invention relates to a non-aqueous electrolyte solution for a lithium secondary battery and a lithium secondary battery including the same, and particularly, to a non-aqueous electrolyte solution for a lithium secondary battery which includes a fluorine-containing compound capable of forming a stable film on the surface of an electrode as an additive, and a lithium secondary battery including the same.

Abstract: A washing machine in which a detergent case is located below a washing tub unit and detergent and wash water are supplied from the detergent case to the washing tub unit by a pump. An overflow hole to prevent overflow of water to the outside the detergent case is provided on the detergent case, and the detergent and the wash water do not overflow the detergent case and are discharged to an outside of the washing machine through the overflow hole when the pump breaks down.